Loading…
Revvity, Inc. is projected to rise to $112.59 by 2027, a +16% move from its current price of $96.79. RVTY is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $94.83 | $96.84 | $98.89 | +0.05% |
| May 30 | $94.05 | $96.88 | $99.80 | +0.10% |
| May 31 | $93.47 | $96.93 | $100.52 | +0.14% |
| Jun 1 | $92.99 | $96.97 | $101.13 | +0.19% |
| Jun 2 | $92.58 | $97.02 | $101.68 | +0.24% |
| Jun 3 | $92.21 | $97.07 | $102.19 | +0.29% |
| Jun 4 | $91.87 | $97.11 | $102.66 | +0.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $91.87 | $97.11 | $102.66 | +0.33% |
| Week 2 | $90.08 | $97.44 | $105.39 | +0.67% |
| Week 3 | $88.80 | $97.76 | $107.63 | +1.01% |
| Week 4 | $87.79 | $98.09 | $109.61 | +1.34% |
| Week 5 | $86.93 | $98.42 | $111.42 | +1.68% |
| Week 6 | $86.20 | $98.75 | $113.13 | +2.02% |
| Week 7 | $85.55 | $99.08 | $114.75 | +2.36% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Revvity, Inc. operates in the health sciences sector, providing solutions, technologies, and services for testing and imaging in diagnostics. Its offerings include instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services, as well as assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc.
in April 2023. Revvity was founded in 1937 and is headquartered in Waltham, Massachusetts.
It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names.
Revvity, Inc. (RVTY) is trading at $96.95 with a market cap of $10.82B, and it ranks 867. The current price sits at the forefront of a forecast horizon, with the 2026 min $82.26, avg $96.95, max $129.76 and sentiment NEUTRAL.
Looking further out, the forecast envisions upside across multiple years, with the 2030 avg price projected at $166.87 and a max of $234.35, followed by continued growth to 2040 and 2050, where the 2040 avg is $316.86 and the 2050 avg is $668.51. These figures imply meaningful long-term appreciation relative to today’s level.
A major floor 22.9% below — a decisive break under it would weaken the trend.
The nearest floor, 15.0% below — buyers have tended to step in here.
The nearest ceiling, 4.3% above — a clean break opens room to run.
A major ceiling 21.7% above — clearing it would confirm fresh momentum.
Key RVTY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RVTY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $96.15 | Buy | $96.42 | Buy |
| MA 10 | $95.75 | Buy | $95.99 | Buy |
| MA 20 | $94.45 | Buy | $94.83 | Buy |
| MA 50 | $91.05 | Buy | $93.59 | Buy |
| MA 100 | $96.44 | Buy | $94.33 | Buy |
| MA 200 | $94.66 | Buy | $95.87 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.38 | Neutral |
| Stoch RSI (14) | 29.00 | Neutral |
| CCI (20) | 40.64 | Neutral |
| Williams %R (14) | -59.89 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -4.17 | Sell |
| Bollinger %B (20,2) | 0.62 | Neutral |
| Stochastic %K (14) | 40.11 | Neutral |
| TRIX (15) | 0.26 | Buy |
| Awesome (5,34) | 3.23 | Buy |
| Ultimate (7,14,28) | 64.41 | Neutral |
| Momentum (10) | -2.51 | Sell |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 96.96 | Sell |
| ADX (14) | 14.73 | Neutral |
| ATR (14) | 1.57 | Info |
The 30-day technical picture is bullish, with sentiment labeled BULLISH. RSI14 sits at 60, with the 50-day simple moving average at $90.62 and the 200-day simple moving average at $94.56. Support is listed at $82.26 and resistance at $101.00.
The 30-day price range spans from a low of $83.68 to a high of $112.33, highlighting a constructive near-term trading band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $82.26 | $96.79 | $128.49 | 0% | Neutral | |
| $91.30 | $112.59 | $145.81 | +16% | Neutral | |
| $103.20 | $129.87 | $173.03 | +34% | Bullish | |
| $118.65 | $151.87 | $206.96 | +57% | Bullish | |
| $124.31 | $161.49 | $224.35 | +67% | Bullish | |
| $128.24 | $168.88 | $238.60 | +74% | Bullish | |
| $130.18 | $173.61 | $249.05 | +79% | Bullish | |
| $134.34 | $181.27 | $263.69 | +87% | Bullish | |
| $150.18 | $204.92 | $301.94 | +112% | Bullish | |
| $163.11 | $224.95 | $335.43 | +132% | Bullish | |
| $208.30 | $301.32 | $472.61 | +211% | Bullish | |
| $400.63 | $627.92 | $1,061.31 | +549% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $82.26 | $96.79 | $113.31 | +0.00% |
| June 2026 | $84.56 | $98.81 | $117.83 | +2.09% |
| July 2026 | $85.96 | $101.09 | $121.82 | +2.31% |
| August 2026 | $84.99 | $100.45 | $122.02 | -0.64% |
| September 2026 | $85.45 | $101.42 | $124.01 | +0.96% |
| October 2026 | $88.14 | $105.01 | $129.16 | +3.54% |
| November 2026 | $88.27 | $105.52 | $130.47 | +0.49% |
| December 2026 | $86.23 | $103.41 | $128.49 | -2.00% |
Click any year to see its month-by-month RVTY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect RVTY to range from $82.26 to $128.49 through 2026. The $96.79 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The RVTY price prediction for 2027 points to an average of $112.59 (low $91.30, high $145.81) — a potential gain of +16% on today's $96.79. A consolidation phase looks the most probable path here.
In 2028, RVTY is projected to trade between $103.20 and $173.03, averaging $129.87 — a potential gain of +34% from today's $96.79. That is up +15% on the projected 2027 average. Momentum favours further upside here.
Revvity, Inc.'s 2029 outlook centres on $151.87, within a $118.65 to $206.96 range. That is up +17% on the projected 2028 average. That marks a +57% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, RVTY could reach as high as $224.35, with a base case around $161.49 and support toward $124.31 — roughly +67% from $96.79. Momentum favours further upside here.
Expect RVTY to range from $128.24 to $238.60 through 2031. The $168.88 average target implies a +74% move from current prices. That is up +5% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The RVTY price prediction for 2032 points to an average of $173.61 (low $130.18, high $249.05) — a potential gain of +79% on today's $96.79. Momentum favours further upside here.
In 2033, RVTY is projected to trade between $134.34 and $263.69, averaging $181.27 — a potential gain of +87% from today's $96.79. That is up +4% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Revvity, Inc.'s 2034 outlook centres on $204.92, within a $150.18 to $301.94 range. That is up +13% on the projected 2033 average. That marks a +112% change versus current levels. Momentum favours further upside here.
By 2035, RVTY could reach as high as $335.43, with a base case around $224.95 and support toward $163.11 — roughly +132% from $96.79. Buyers look set to stay in control over this stretch.
Expect RVTY to range from $208.30 to $472.61 through 2040. The $301.32 average target implies a +211% move from current prices. That is up +34% on the projected 2035 average. Momentum favours further upside here.
The RVTY price prediction for 2050 points to an average of $627.92 (low $400.63, high $1,061.31) — a potential gain of +549% on today's $96.79. Buyers look set to stay in control over this stretch.
Investing $1,000 in RVTY today (≈ 10.331646 RVTY) could be worth
$6,487.44
+$5,487.44 (+549%) by 2050 · US Dollar
Based on the average projected RVTY price of $627.92 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RVTYwould be worth at today's price.
$1,000 invested in RVTY on May 27, 2025 (≈ 10.842459 RVTY) would be worth
$1,049.44
+$49.44 (+4.9%) today · 1.05× · US Dollar
Based on a RVTY entry price of $92.23 vs. today's $96.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $94.8 | $1,020.99 | +2.1% |
| 1 month ago | $86.8 | $1,115.09 | +11.5% |
| 3 months ago | $99.01 | $977.58 | -2.2% |
| 6 months ago | $104.41 | $927.02 | -7.3% |
| 1 year ago | $92.23 | $1,049.44 | +4.9% |
| All time (5.0y) ago | $141.76 | $682.77 | -31.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RVTY forecast.
Our base-case forecast reaches $190.00 around 2034.
Implied market cap at $190.00: $21.2B
The multi-year outlook shows a clear uphill trajectory in the forecasted averages. For 2030, the average price is $166.87 with a 72.1% ROI and a bullish sentiment. The path continues to 2040, where the average price is $316.86 with a 226.8% ROI and a bullish sentiment.
By 2050, the forecast reaches an average of $668.51 with a 589.5% ROI and a bullish sentiment. Max price projections for these years extend to $234.35 in 2030, $505.42 in 2040, and $1,152.95 in 2050. These numbers point to substantial long-term upside, while remaining estimates that depend on future market conditions.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $166.87 with a min of $127.33 and a max of $234.35. The ROI is 72.1% and sentiment is BULLISH.
Forecasts show positive upside across multiple years, with an average price rising to $166.87 by 2030 and a max of $234.35. ROI progresses from 18.5% in 2027 to 589.5% by 2050; sentiment is predominantly BULLISH in later years.
Yes. The forecast max reaches $214.75 in 2029 and $234.35 in 2030, indicating a path above $200 within the forecast horizon.
Current price is $96.95 and market cap is $10.82B.
The 30-day range is from $83.68 to $112.33.
Revvity, Inc. Community Discussion
0Share your Revvity, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.